The Contraceptive Vaginal Ring in Women With Renal and Liver Transplantation: Analysis of Preliminary Results

Paternoster, D.M.; Riboni, Francesca; Bertolino, Mariela; Garofalo, Greta; Lazzarich, Elisa; Surico, N; Stratta, Piero

doi:10.1016/j.transproceed.2010.03.132

Cited by 27 publications

(9 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…To avoid monthly fluctuations in drug concentrations, patients using combined methods should use them continuously, without a hormonefree interval. Although 1 study suggests that immunosuppressant concentrations remain stable with use of the contraceptive vaginal ring, 259 both the ring and the patch are sufficiently similar to COCs that, until further data are available, they should be used with the same precautions that apply to COCs. Drug interactions with progestin-only methods are uncommon; however, monitoring cyclosporine concentrations is advisable.…”

Section: Adolescent Recipients Of Solid Organ Transplantationmentioning

confidence: 99%

“…Patients who have established normal organ function and are stable at least 6 to 8 months after transplantation can use any of the currently available hormonal contraceptives, provided they do not have other contraindications to the estrogen component. 58,254,257,[258][259][260] Contraindications to estrogen, however, occur more commonly in transplant recipients. For example, COCs should not be prescribed to patients with active liver dysfunction or coronary artery disease.…”

Section: Adolescent Recipients Of Solid Organ Transplantationmentioning

confidence: 99%

See 1 more Smart Citation

Contraception for Adolescents

Ott

Sucato²

2014

Pediatrics

245

133

View full text Add to dashboard Cite

A working knowledge of contraception will assist the pediatrician in both sexual health promotion as well as treatment of common adolescent gynecologic problems. Best practices in adolescent anticipatory guidance and screening include a sexual health history, screening for pregnancy and sexually transmitted infections, counseling, and if indicated, providing access to contraceptives. Pediatricians’ long-term relationships with adolescents and families allow them to help promote healthy sexual decision-making, including abstinence and contraceptive use. Additionally, medical indications for contraception, such as acne, dysmenorrhea, and heavy menstrual bleeding, are frequently uncovered during adolescent visits. This technical report provides an evidence base for the accompanying policy statement and addresses key aspects of adolescent contraceptive use, including the following: (1) sexual history taking, confidentiality, and counseling; (2) adolescent data on the use and side effects of newer contraceptive methods; (3) new data on older contraceptive methods; and (4) evidence supporting the use of contraceptives in adolescent patients with complex medical conditions.

show abstract

Section: Adolescent Recipients Of Solid Organ Transplantationmentioning

confidence: 99%

Section: Adolescent Recipients Of Solid Organ Transplantationmentioning

confidence: 99%

Contraception for Adolescents

Ott

Sucato²

2014

Pediatrics

245

133

View full text Add to dashboard Cite

show abstract

“…Use of the contraceptive vaginal ring has been described in a prospective group of 17 renal and liver transplant patients. There were no cases of rejection, need to change immunosuppressive medication, or contraceptive failure [27]. The COCs in these studies contain both 20 and 35 mcg of estradiol and a variety of progestins.…”

Section: Combined Hormonal Contraceptionmentioning

confidence: 89%

Reproductive health care after transplantation

Krajewski¹,

Sucato²

2014

Best Practice & Research Clinical Obstetrics & Gynaecol

View full text Add to dashboard Cite

“…41 Both the transdermal patch and vaginal ring were studied in transplant patients and had favorable results. 24,43 The combined hormonal oral contraceptive pills, patch, and ring are in category 4 (unacceptable health risk) in the US MEC in patients with complicated cases, but they are in category 2 in uncomplicated cases. 21 Combined hormonal contraceptives should not be considered first-line options by themselves for transplant patients because of their high failure rate with typical use.…”

Section: Combined Hormonal Contraceptivesmentioning

confidence: 99%